The investment seeks long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapGrowth
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MBCSX | 19.29 | N/A | N/A |
| MassMutual Blue Chip Growth R5 | |||
| LVAFX | 13.52 | N/A | N/A |
| LSV Global Managed Volatility Investor | |||
| PRERX | 30.12 | N/A | N/A |
| Principal Real Estate Securities R3 | |||
| FMADX | 10.60 | N/A | N/A |
| Fidelity SAI Merger Arbitrage | |||
| CRVRX | 8.92 | -0.01 | -0.11% |
| NYLIM CBRE Real Estate Fund Investor Cl | |||
A.I.dvisor indicates that over the last year, IMORX has been closely correlated with FSMAX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMORX jumps, then FSMAX could also see price increases.
| Ticker / NAME | Correlation To IMORX | 1D Price Change % | ||
|---|---|---|---|---|
| IMORX | 100% | N/A | ||
| FSMAX - IMORX | 93% Closely correlated | N/A | ||
| RPTIX - IMORX | 91% Closely correlated | N/A | ||
| TRQZX - IMORX | 91% Closely correlated | N/A | ||
| PEMGX - IMORX | 85% Closely correlated | N/A | ||
| PMBCX - IMORX | 84% Closely correlated | N/A | ||
More | ||||